Perrigo Company Announces Appointment of New Bo... ( ALLEGAN Mich. July 11 /- Perrigo ...)

Perrigo Company Announces Appointment of New Board Member

Date:7/11/2008

ALLEGAN, Mich., July 11 /PRNewswire-FirstCall/ -- Perrigo Company (Nasdaq: PRGO; TASE) today announced that its Board of Directors has appointed Ellen R. Hoffing as a new director of the Company.

Joseph C. Papa, Perrigo's Chairman, President and Chief Executive Officer, stated, "Ellen Hoffing's outstanding background has served her well in leadership roles at several pharmaceutical and healthcare companies. Her broad business and strategic acumen will allow her to make excellent contributions to our Board. We are pleased to welcome Ellen to the Perrigo Board of Directors."

Since 2006, Ellen R. Hoffing, 51, has served as President and Chief Executive Officer of Applied NeuroSolutions, Inc., a development stage biopharmaceutical company focused on diagnostics and therapeutics for the treatment of Alzheimer's Disease. She has also served as Chairman of Applied NeuroSolutions' Board of Directors since December 2007. Ms. Hoffing has extensive experience in the pharmaceutical industry, including management, strategic planning and operations, given her prior senior positions at American Pharmaceutical Partners (2005-2006), Baxter Healthcare (2002-2005), and Searle Pharmaceuticals (1983-2000). Ms. Hoffing has a bachelor of science in accountancy from the University of Illinois at Urbana -- Champaign and a masters in management from the Kellogg Graduate School of Management at Northwestern University.

Perrigo Company is a leading global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and prescription pharmaceuticals, nutritional products, active pharmaceutical ingredients (API) and consumer products. The Company is the world's largest manufacturer of OTC pharmaceutical products for the st
'/>"/>

SOURCE Perrigo Company
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine news :

1. Perrigo Vice Chair Mori Arkin To Retire After 30 Years of Service
2. Perrigo Company to Host Analyst Meeting on September 18, 2007
3. Perrigo Company Announces FDA Approval for Ciclopirox Topical Solution
4. Perrigo Company Announces FDA Approval for Ciclopirox Topical Solution
5. Perrigo Confirms Filing for Generic Version of Mucinex(R) and Announcement of Lawsuit by Adams Respiratory
6. Perrigo Company Will Release First Quarter Fiscal 2008 Results on November 1, 2007
7. Perrigo Company Announces Dividend Increase
8. Perrigo Announces that Dexcels Settlement with AstraZeneca Allows OTC Omeprazole Launch Following Final FDA Approval
9. Perrigo Company to Present at The 26th Annual JPMorgan Healthcare Conference
10. Perrigo Acquires UK OTC Store Brand Supplier
11. Perrigo Company Authorizes Continuation of Share Repurchase Program and Announces Quarterly Dividend

Post Your Comments:

(Date:11/30/2009)...radiation dose was equivalent to 113 chest X-rays,...Day News) -- More than half of patients who have a...ssary imaging tests that expose them to extra radi...8 CT abdominal and pelvic series were performed on...he patients were 30 to 50 years of age. The resear...

(Date:11/30/2009)...mic seems to ebb, CDC notes a rise in child deaths...althDay News) -- U.S. health officials said Monda...he wane nationally, even as the number of American.... , The latest report, released Monday by the U...C), finds that "visits to doctors for influenza-li...

(Date:11/30/2009)...NEW ORLEANS, Nov. 30 SE... the global corporation Sodexo will hold a rally T... and Maintenance headquarters, 3800 Desire Parkway...licy and arbitrary disciplinary policies that targ...n ill family member. Sodexo employees who clean sc...

(Date:11/30/2009)..., CARDIFF, Calif., Nov. 30 /PRNewswire-FirstCall/...imindinc.com) is pleased to announce the Company,s...ilable for purchase. The game, "Think-Tac-Toe" is ...ay the game with the power of their mind and is ge...sold online at a price of $49 and can be purchased...

(Date:11/30/2009)... , Study Uses Tent To Simulate H... Nov. 30 Distance runne...ls are known to improve their performance during r...ailure patients, who suffer from fatigue, improve ...ke, high-altitude simulator? ,, That is the que...

Breaking Medicine News(10 mins):Health News:CT Scan Patients May Get Unnecessary Imaging 2 Health News:U.S. Swine Flu Cases Chart Sharp Decline 2 Health News:U.S. Swine Flu Cases Chart Sharp Decline 3 Health News:As H1NI Hits New Orleans in Force: School Custodians to Hold Rally to Call on Contractor to Stop Penalizing Workers Coping With Illness 2 Health News:First Thought-Controlled Game Complete From Jedi Mind, Inc. 2 Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 2 Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 3 Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 4

[0] CT Scan Patients May Get Unnecessary Imaging [0] U.S. Swine Flu Cases Chart Sharp Decline [1] As H1NI Hits New Orleans in Force: School Custodians to Hold Rally to Call on Contractor to Stop Penalizing Workers Coping With Illness [0] First Thought-Controlled Game Complete From Jedi Mind, Inc.[1] Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients?

...e insurer MedAmerica announces a $70 million acqui... Combined Insurance Company of America, part of th...90-year-old leading provider of supplemental accid...on completion, the acquired block of 11,000 contra...

...2 Million Marylanders , , BALTIMORE, April 14 ... Surgeon General (2002-2006), President of the non...person of the Partnership to Fight Chronic Disease...and local leaders from Maryland to launch a partne...

...ciences, Inc. (GNS) today announced that it has en...ersity of Texas M.D. Anderson Cancer Center aimed...ical data from patients with glioblastoma, the mos...tion of groundbreaking genetic data and clinical o...

...c (low blood sugar) episodes that require a visit ... of dementia in elderly patients with type 2 diabe...ision of Research study in the Journal of the Ame...lood sugar should be controlled in patients with t...

... , Montreal, April 14 2009 Begin treatment as ea...ems to apply to most diseases except HIV-AIDS, whi... cells called "CD4+" cells have disappeared. The r...he findings show that the risk of death in seropos...

...o Nordisk and Proves His High Performance Career i...il 14 Novo Nordisk, a world leader in diabetes ...ld race car driver, Charlie Kimball, now driving i...k. Novo Nordisk is the maker of Levemir(R) (insuli...

Other Medicine News:Health News:Insurer Grows with $70 Million Acquisition 2 Health News:National Health Experts Launch Bipartisan Coalition to Fight Chronic Disease 2 Health News:National Health Experts Launch Bipartisan Coalition to Fight Chronic Disease 3 Health News:National Health Experts Launch Bipartisan Coalition to Fight Chronic Disease 4 Health News:Gene Network Sciences Announces Brain Cancer Collaboration With M.D. Anderson 2 Health News:Gene Network Sciences Announces Brain Cancer Collaboration With M.D. Anderson 3 Health News:Low Blood Sugar Events Increase Dementia Risk in Elderly Patients With Type 2 Diabetes, Kaiser Permanente Study Finds 2 Health News:Low Blood Sugar Events Increase Dementia Risk in Elderly Patients With Type 2 Diabetes, Kaiser Permanente Study Finds 3 Health News:Low Blood Sugar Events Increase Dementia Risk in Elderly Patients With Type 2 Diabetes, Kaiser Permanente Study Finds 4 Health News:Treating HIV earlier to decrease the risk of death 2 Health News:Indy Lights Racer Charlie Kimball Doesn't Let Diabetes Slow Him Down 2 Health News:Indy Lights Racer Charlie Kimball Doesn't Let Diabetes Slow Him Down 3 Health News:Indy Lights Racer Charlie Kimball Doesn't Let Diabetes Slow Him Down 4 Health News:Indy Lights Racer Charlie Kimball Doesn't Let Diabetes Slow Him Down 5

Insurer Grows with $70 Million Acquisition National Health Experts Launch Bipartisan Coalition to Fight Chronic Disease Gene Network Sciences Announces Brain Cancer Collaboration With M.D. Anderson Low Blood Sugar Events Increase Dementia Risk in Elderly Patients With Type 2 Diabetes, Kaiser Permanente Study Finds Treating HIV earlier to decrease the risk of death Indy Lights Racer Charlie Kimball Doesn't Let Diabetes Slow Him Down

(Date:11/30/2009)...RNewswire/ -- Minimally-invasive procedures are in...ticularly in oncology, cardiology and women,s heal...uided navigation expected to reach $600 million by...ered by minimally-invasive procedures, including s...fort and faster patient throughput. ,, (Logo:...

(Date:11/30/2009)..., November 30 Optoacoustics has an...nnel microphone, the most advanced,optical microph...ance imaging,(fMRI) environments. , The t...ard for fiber,optic microphone technology, providi...ncy adaptive noise cancelling. The FOMRI-III also ...

(Date:11/30/2009)...Newswire/ -- Stemline Therapeutics, Inc., a privat...ding developer of oncology compounds directed to c...ity of Texas M.D. Anderson Cancer Center (Houston,...laboration. As part of this collaboration, M.D. An...rial of SL-401 in patients with acute myeloid leuk...

[0] Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures [0] New Generation Noise Cancelling Optical Microphone Paves Way for Advanced Brain and Speech Research [0] Stemline Therapeutics Expands Clinical Oncology Program Directed at Cancer Stem Cells With Addition of M.D. Anderson Cancer Center

...ria and CHAPEL HILL, N.C., US, March 06, 2007,/PRN...phan") and,Lantibio, Inc. ("Lantibio") today annou...trolled, double-blinded Phase II clinical,study of...c,fibrosis ("CF"). Moli1901 is being developed by ...ialization agreement with,Lantibio. The study, per...

...(BUSINESS WIRE)--Mar 7, 2007 - Accentia,Biopharmac...ters at,the Annual Meeting of the American Academy...23 - 27, 2007 in San Diego, CA. The,posters discus...s,(ENTs) and allergists in the U.S., U.K., France,...S), the knowledge and attitudes of,the fungal etio...

Other Medicine Technology:AOP Orphan Pharmaceuticals and Lantibio Announce Positive Phase II,Study with Novel Cystic Fibrosis Therapy 2 AOP Orphan Pharmaceuticals and Lantibio Announce Positive Phase II,Study with Novel Cystic Fibrosis Therapy 3 AOP Orphan Pharmaceuticals and Lantibio Announce Positive Phase II,Study with Novel Cystic Fibrosis Therapy 4 Accentia Biopharmaceuticals Scientific Presentations Demonstrate,Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at,the Annual Meeting of the American Academy of Allergy, Asthma, and,Immunology 2 Accentia Biopharmaceuticals Scientific Presentations Demonstrate,Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at,the Annual Meeting of the American Academy of Allergy, Asthma, and,Immunology 3 Accentia Biopharmaceuticals Scientific Presentations Demonstrate,Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at,the Annual Meeting of the American Academy of Allergy, Asthma, and,Immunology 4 Accentia Biopharmaceuticals Scientific Presentations Demonstrate,Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at,the Annual Meeting of the American Academy of Allergy, Asthma, and,Immunology 5

AOP Orphan Pharmaceuticals and Lantibio Announce Positive Phase II,Study with Novel Cystic Fibrosis Therapy Accentia Biopharmaceuticals Scientific Presentations Demonstrate,Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at,the Annual Meeting of the American Academy of Allergy, Asthma, and,Immunology

Electrohydraulic Lithotripsy Probe for AEH-2 & AEH-3

S-Series Cystourethroscope Short Bridge, examining

S-Series Cystourethroscope Short Bridge, double-horn

Laser Flat-wire

Medicine Products:

Electrohydraulic Lithotripsy Probe for AEH-2 & AEH-3 S-Series Cystourethroscope Short Bridge, examining S-Series Cystourethroscope Short Bridge, double-horn Laser Flat-wire

Perrigo Company Announces Appointment of New Bo...( ALLEGAN Mich. July 11 /- Perrigo ...),Health